Transplant for Older Patients with Dr. Nandita Khera - 2022
Dr. Nandita Khera discusses why and when transplants can be recommended for older patients in this podcast episode.
Podcast Episodes
Our patients, families, and caregivers have been asking us for more ways to learn about rare blood cancers and bone marrow failure diseases. So, we're coming to you today, thanks to generous support from individual donors and our corporate partners.
Treatment Options for MDS (Myelodysplastic Syndromes) with Dr. Rory Shallis - 2022
Dr. Rory Shallis discusses a variety of current treatments for MDS, or Myelodysplastic Syndromes
Treating MDS after Hypomenthylating Failure with Dr. Jacqueline Garcia - 2022
Dr. Jacqueline Garcia discusses the use of hypomenthylating agents.
MDS Treatment, Inqovi: Dr. Amer Zeidan Explains the Use of this Treament
The recently-approved hypomethylating treatment, Inoqvi, is a daily oral version of two IV or subcutaneous medications. Listen to Dr. Amer Zeidan of Yale Cancer Center explain which MDS patients could qualify, and what it means for their treatment at the link.
Dr. Eunice Wang discusses Secondary MDS
Dr. Eunice Wang explains the origin and treatment of secondary MDS. Dr. Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Center.
Dr. David Steensma discusses MDS and toxins with Leigh Clark, Patient Educator
Dr. David Steensma discusses MDS and toxins with Leigh Clark, Patient Educator. Dr. Steensma is an associate professor at Harvard Medical School and faculty member in the leukemia program at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, Massachusetts and the Edward P. Evans Chair in MDS at Dana-Farber Cancer Institute
AAMDSIF Podcast for Patients: Dr. Yacoub explains MDS/MPN Overlap Diagnosis and Treatment
Dr. Abdulraheem Yacoub talks with Leigh Clark about MDS-MPN overlap. He includes how molecular testing is used in determining treatment options.
He also discusses the newly approved drug, Luspatercept, for the treatment of MDS and MDS-MPN overlap syndromes.
AAMDSIF Podcast for Patients: Dr. Amit Verma discusses approval of Luspatercept for certain MDS patients
Here is a discussion of the recent approval of Luspatercept with Dr. Amit Verma, Director of the Division of Hematologic Malignancies and a Professor of Oncology at the Albert Einstein College of Medicine in New York City. He explains the results of clinical trials and describes which MDS patients have the best response to this medication.
#MDS #treatingMDS
AAMDSIF Podcast for Patients: Dr. Gustavo Rivero discusses Low-Risk MDS
Dr. Gustavo Rivero describes strategies for the management of Low-Risk MDS, or Myelodysplastic Syndromes. He details supportive care for these patients, including transfusions and iron overload therapies.
Dr. Vu Duong explains High-Risk and Low-Risk MDS
Dr Vu Duong explains risk classifications for MDS. He dives into IPSS and IPSS-R scores, focused on helping patients to understand the meanings of high-risk and low-risk MDS.
2025 Patient Education Sponsors
Our Diamond Level Sponsors:
Our Silver Level Sponsors:
Our Bronze Level Sponsors:
